UNSPSC 51111707: Deoxycoformycin or pentostatin

This classification denotes an adenosine deaminase inhibitor with the molecular formula C11H16N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 395575MZO7, chemically known as (r)-3-(2-deoxy-beta-d-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol but generally known as pentostatin, which bears US NIH Compound Identifier 40926. European Medicines Agency schedules Pentostatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09704MIG.

UNSPSC 51111707 Deoxycoformycin or pentostatin, a Commodity code, covers the procurement of pentostatin (also known as deoxycoformycin), a chemotherapy agent used in the treatment of hematologic malignancies, particularly hairy cell leukemia and cutaneous T-cell lymphoma. State and local governments purchase this pharmaceutical through health departments, public health agencies, state Medicaid programs, and public hospital systems that operate oncology services or provide cancer treatment to indigent or underinsured populations. The code captures both bulk pharmaceutical procurement and unit-dose acquisitions, typically through competitive bidding processes tied to formulary adoption or standing supply agreements.

The source contains no recent state or local contract opportunities posted under this code as of October 2026. Without documented solicitations in the recent-opportunities block, characterization of issuing-body concentration, geographic spread, and representative procurement patterns cannot be established. Practitioners tracking this code should monitor state Medicaid procurement offices, public hospital purchasing departments, and state pharmaceutical cooperative purchasing vehicles (particularly those operating statewide or regional oncology procurement programs) for future activity; pentostatin procurement typically appears episodically as formularies are updated or treatment protocols shift rather than through steady-state continuous bidding.